Latest Ontario Cancer Institute Stories

Biggest Ever Private Donation to Cancer Research in Canada TORONTO, Jan. 21, 2013 /PRNewswire/ - Canadian philanthropists Emmanuelle Gattuso, Allan Slaight and the Slaight family made history today with a $50 million gift to The Princess Margaret Cancer Foundation. The extraordinary donation is the biggest ever private gift to cancer research in Canadian history and will advance the Princess Margaret Cancer Centre's Personalized Cancer Medicine initiative. Ms. Gattuso and Mr....

Largest healthcare initiative of its kind in Canada launched to conquer cancer in our lifetime TORONTO, April 12, 2012 /PRNewswire/ - Amidst the skirl of the pipes and a glistening 400-ounce bar of solid gold symbolizing a new gold standard in cancer care, The Princess Margaret Hospital Foundation today announced its new 'BELIEVE IT!' campaign -- a BILLION DOLLAR CHALLENGE to accelerate Personalized Cancer Medicine at The Princess Margaret. "We live in the Golden Age of cancer...

TORONTO, April 3, 2012 /PRNewswire/ -- Mobile Integrated Systems, Inc (OTCBB:LOTID), operating through its wholly-owned subsidiary Mobilotto Systems, Inc. ("Mobilotto"), today announced the deployment of a mobile lottery application for The Princess Margaret Hospital Foundation Lotteries. This Android application debuts the first mobile lottery application in Canada for a charitable lottery and allows users to register, receive notifications and order tickets directly from their...

A second, larger clinical research study led by breast cancer specialists at Princess Margaret Hospital (PMH) has again proven that comparing a new biopsy of progressing or recurring cancer with that of the original cancer can dictate a change in treatment. The results are published online today ahead of print in the Journal of Clinical Oncology.  Principal investigator Dr. Eitan Amir, medical oncologist in the PMH Cancer Program, University Health Network, says clinicians involved...

Princess Margaret Hospital researchers identify a key enzyme that affects radiation response in head and neck cancer patientsCancer researchers at Princess Margaret Hospital (PMH) have discovered that targeting an enzyme called Uroporphyrinogen Decarboxylase (UROD) can sensitize diseased tissue to radiation and chemotherapy, which could mean fewer side effects for individuals with head and neck cancer.The findings, published online today in Science Translational Medicine...

 Dr. John Dick, Senior Scientist at the Ontario Cancer Institute, the research arm of Princess Margaret Hospital, co-led a multinational team that has developed the first leukemia therapy that targets a protein, CD123, on the surface of cancer stem cells that drive acute myeloid leukemia (AML), which is an aggressive disease with a poor outcome.Dr. Richard Lock is leading the clinical trial in Australia that expands on research suggesting that antibodies targeting cancer stem cells...